Mary Canavan Selected Research

Mary Canavan Research Topics

5	Inflammation (Inflammations) 11/2022 - 01/2016
3	Arthritis (Polyarthritis) 01/2020 - 01/2017
3	Psoriatic Arthritis 09/2019 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 12/2018 - 01/2016
2	Arthralgia (Joint Pain) 01/2018 - 01/2017
1	Necrosis 01/2019
1	Rheumatoid Arthritis 01/2018
1	Disease Progression 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Colitis 10/2014
1	Shock 07/2014

2	LigandsIBA 01/2021 - 01/2018
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019 - 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Chemokine ReceptorsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Phosphodiesterase 4 InhibitorsIBA 01/2019
1	SuspensionsIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	CytokinesIBA 12/2018
1	IpilimumabIBA 01/2018
1	pembrolizumabIBA 01/2018
1	AntigensIBA 01/2018
1	NivolumabIBA 01/2018
1	AntibodiesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	3- (3- pyridinyl)- 1- (4- pyridinyl)- 2- propen- 1- oneIBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Janus KinasesIBA 01/2016
1	SodiumIBA 10/2014
1	Interleukin-12 Subunit p40IBA 07/2014

1	Therapeutics 01/2019
1	Ligation 12/2018